Norris CM - Search Results

1

Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience.

Haddad R, Colevas AD, Tishler R, Busse P, Goguen L, Sullivan C, Norris CM, Lake-Willcutt B, Case MA, Costello R, Posner M. Haddad R, et al. Among authors: norris cm. Cancer. 2003 Jan 15;97(2):412-8. doi: 10.1002/cncr.11063. Cancer. 2003. PMID: 12518365 Free article.

2

Phase I study of C-TPF in patients with locally advanced squamous cell carcinoma of the head and neck.

Haddad RI, Tishler RB, Norris C, Goguen L, Balboni TA, Costello R, Wirth L, Lorch J, Andreozzi B, Annino D, Posner MR. Haddad RI, et al. J Clin Oncol. 2009 Sep 20;27(27):4448-53. doi: 10.1200/JCO.2009.22.1333. Epub 2009 Aug 24. J Clin Oncol. 2009. PMID: 19704061 Clinical Trial.

3

A Phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck.

Tishler RB, Norris CM Jr, Colevas AD, Lamb CC, Karp D, Busse PM, Nixon A, Frankenthaler R, Lake-Willcutt B, Costello R, Case M, Posner MR. Tishler RB, et al. Among authors: norris cm jr. Cancer. 2002 Oct 1;95(7):1472-81. doi: 10.1002/cncr.10873. Cancer. 2002. PMID: 12237916 Free article. Clinical Trial.

4

Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment.

Haddad R, Tishler RB, Norris CM, Mahadevan A, Busse P, Wirth L, Goguen LA, Sullivan CA, Costello R, Case MA, Posner MR. Haddad R, et al. Among authors: norris cm. Oncologist. 2003;8(1):35-44. doi: 10.1634/theoncologist.8-1-35. Oncologist. 2003. PMID: 12604730 Free article. Review.

5

Prospective phase II trial of PFL-induction chemotherapy followed by definitive local treatment for advanced squamous cell carcinoma of the head and neck: 10-year follow-up.

Devlin PM, Kazakin J, Adak S, Li Y, Norris CM, Tishler RB, Clark JR, Busse PM, Posner MR. Devlin PM, et al. Among authors: norris cm. Am J Clin Oncol. 2004 Aug;27(4):369-75. doi: 10.1097/01.coc.0000071518.80534.ad. Am J Clin Oncol. 2004. PMID: 15289730 Clinical Trial.

6

Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer.

McCollum AD, Burrell SC, Haddad RI, Norris CM, Tishler RB, Case MA, Posner MR, Van den Abbeele AD. McCollum AD, et al. Among authors: norris cm. Head Neck. 2004 Oct;26(10):890-6. doi: 10.1002/hed.20080. Head Neck. 2004. PMID: 15390197

7

Induction chemotherapy in locally advanced squamous cell cancer of the head and neck: evolution of the sequential treatment approach.

Posner MR, Haddad RI, Wirth L, Norris CM, Goguen LA, Mahadevan A, Sullivan C, Tishler RB. Posner MR, et al. Among authors: norris cm. Semin Oncol. 2004 Dec;31(6):778-85. doi: 10.1053/j.seminoncol.2004.09.007. Semin Oncol. 2004. PMID: 15599855 Review.

8

Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer.

Guadagnolo BA, Haddad RI, Posner MR, Weeks L, Wirth LJ, Norris CM, Sullivan CA, Goguen L, Busse PM, Tishler R. Guadagnolo BA, et al. Among authors: norris cm. Am J Clin Oncol. 2005 Aug;28(4):371-8. doi: 10.1097/01.coc.0000162423.13431.8d. Am J Clin Oncol. 2005. PMID: 16062079 Clinical Trial.

9

Phase I study of gefitinib plus celecoxib in recurrent or metastatic squamous cell carcinoma of the head and neck.

Wirth LJ, Haddad RI, Lindeman NI, Zhao X, Lee JC, Joshi VA, Norris CM Jr, Posner MR. Wirth LJ, et al. Among authors: norris cm jr. J Clin Oncol. 2005 Oct 1;23(28):6976-81. doi: 10.1200/JCO.2005.02.4182. Epub 2005 Sep 19. J Clin Oncol. 2005. PMID: 16172459 Clinical Trial.

10

A 49-year-old male with locally advanced squamous cell carcinoma of the head and neck: the case for sequential chemoradiotherapy.

Haddad R, Norris CM, Posner MR. Haddad R, et al. Among authors: norris cm. Clin Adv Hematol Oncol. 2003 Jan;1(1):58-60; discussion 61-2. Clin Adv Hematol Oncol. 2003. PMID: 16227961 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

436 results

Search Page

Filters